65 algorithm-development-"Multiple"-"Prof"-"UNIS" positions at Baylor College of Medicine
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
of the lab is to identify the novel molecular signaling pathways and regulation in glial cell development and associated disorders using molecular, cellular, physiological, and neurobehavioral approaches. Job
-
clinical activities. Evaluates and analyzes data independently. Establishes new research protocols and procedures. Develops service line focused on peer support services participating in all aspects
-
of the BCM program is to prepare our fellows to function as independent scientist-clinicians and to provide an advanced comprehensive training opportunity for fellows to gain competence in adult
-
. Analyzes large data sets. Analyzes next generation sequencing data (e.g., RNS-seq, whole genome/exome sequencing). Uses state-of-the-art bioinformatical and statistical tools. Develops new statistical
-
. Establishes new research protocols and procedures. Develops service line focused on peer support services participating in all aspects necessary to accomplish this goal. Develops projects focused on peer
-
/or research supervisors. Documents clinical activities. Evaluates and analyzes data independently. Establishes new research protocols and procedures. Develops service line focused on peer support
-
, metabolism, and the development and treatment of metabolic diseases such as obesity and cancer. The goal is to identify nutritional interventions and metabolic pathways for prevention and treatment
-
translational research focuses on ligandomics, a new omics technology engineered by our group, for drug target discovery and novel therapy development to treat ocular diseases, including glaucoma, diabetic
-
translational research focuses on ligandomics, a new omics technology engineered by our group, for drug target discovery and novel therapy development to treat ocular diseases, including glaucoma, diabetic
-
translational research focuses on ligandomics, a new omics technology engineered by our group, for drug target discovery and novel therapy development to treat ocular diseases, including glaucoma, diabetic